SAFC and Vivalis launch high yield EB66 media
SAFC and Vivalis have launched a new media designed to allow the latter’s commonly used virus producing EB66 cell line to grow at higher cell densities and produce higher yields.
Archives for April 27, 2009
Pfizer’s stem cell unit and UCL focus on eye disorders
Pfizer’s development deal with stem-cell researchers at University College of London’s (UCL) Institute of Opthalmology, aimed at reversing vision loss in AMD, has drawn a great deal of interest from investors and the drug industry alike.
Xspray grows with demand for manufacturing tech
Xspray has doubled its personnel and laboratory space in response to demand for its manufacturing service, which is designed to overcome the drawbacks associated with micronisation.
Patheon to make Oros-based depression and allergy drugs
Canada’s Patheon has been contracted to commercialise treatments for allergy and depression using the Oros controlled release technology at its manufacturing facility in Cincinnati, US.
Parexel’s cancellations double as profit growth stalls
Parexel posted a doubling in cancellations in Q3 of its fiscal year, with profits remaining flat as an eight per cent boost in service revenue was offset by higher operating expenses.
Novozymes begins work on Chinese bHA plant
Novozymes Biopharma is building a new Bacillus-based hyaluronic acid (bHA) production facility in China to meet “increasing demand” for the substance that has drug delivery applications.